During National Cancer Research Month, we honor the courage of patients battling this relentless disease. At Clasp Therapeutics, our mission is clear: to transform the lives of patients everywhere by mastering the discovery, development, and delivery of off-the-shelf precision immunotherapies. #CancerResearch #PrecisionMedicine #Immunotherapy #AimToCure
Clasp Therapeutics’ Post
More Relevant Posts
-
❓Have you read the most recent Global Liver Institute Liver Cancer News article? Highlights include: ➡️ Accelerated Refile for PD-1 Liver Cancer Combo After Surprise FDA Rejection ➡️ Growing Awareness Between Alcohol and Cancer Risk ➡️ New Clinical Tool Can Help Identify Patients at High Risk for Liver Cancer Read the full article👇 https://ow.ly/2p2J50SSYxI #MedEd #HCC #LiverCancer
To view or add a comment, sign in
-
Join the Panome Bio team at the European Association for Cancer Research (EACR) 2024 Congress in Rotterdam, Netherlands! Stop by booth 92A from June 10-13 to learn how our unique multi-omic capabilities enable important solutions for cancer research such as targeted therapy development, patient stratification, and much more. #cancerresearch #metabolomics #proteomics #multiomics
To view or add a comment, sign in
-
Medical Doctor | Master of Science in Translational Medical Research @HeidelbergUni | Postdoctoral Scholar @UCSD
We've just published our study that could revolutionize treatment options for unresectable appendiceal adenocarcinoma (AA). A first of its kind, our phase 2 study examines the efficacy and safety of combining atezolizumab with bevacizumab (Atezo+Bev) in battling advanced AA. With limited options available, our research offers a beacon of hope where previously there was little. This pioneering study leverages the synergy of VEGF and PD-1 inhibition—a strategy that’s shown promise in other tumor types—to potentially pioneer a new path for AA treatments. It's a stride forward in precision medicine, offering a personalized and targeted approach for a disease that has long been an orphan in the cancer treatment landscape. To read more about the outcomes: https://lnkd.in/dEY4tuAH #Oncology #ClinicalResearch #MedicalInnovation #CancerCare #Atezolizumab #Bevacizumab
To view or add a comment, sign in
-
Healthcare AI enthusiastic | Registered Pharmacist | Artificial Intelligence | 👑NASA Hackathon 24| Chatbot developer | WordPress Expert | Healthcare Problem Solver 🤩
*Revolutionizing Cancer Care* 🧪 Pharmacy is at the forefront of the fight against cancer! Exciting new therapies are targeting cancer cells like never before. 🎯 *Immunotherapy* : Empowering the body's immune system to combat cancer. *Targeted Drug Delivery*: Delivering medication directly to cancer cells, minimizing side effects. Let's explore these groundbreaking advancements together! #pharmacy #cancertherapy #medicalscience #healthcare #innovation
To view or add a comment, sign in
-
🎈Exciting research on the role of Peroxiredoxins in cancer development highlights their potential as key targets for improving cancer therapeutics and patient survival. Explore the full paper here: https://lnkd.in/gSEa5pwB.. #Peroxiredoxins #CancerResearch #Antioxidants
To view or add a comment, sign in
-
Lung cancer remains one of the most prevalent forms of Cancer worldwide, often diagnosed at a late stage when treatment options are more limited. This World Lung Cancer Day, by fostering a greater understanding of the disease and supporting efforts to combat it, we at COD aim to advance clinical research and drug development, and to emphasize the importance of early detection. To know more about us, write to us at bd@cod-research.com Designing Therapies for Future #WorldLungCancerDay2024 #WLCD24 #ClosetheCareGap #EveryoneDeservesAccesstoCancerCare #CODResearch
To view or add a comment, sign in
-
Head of Research, Science and Education “Luis Carlos Sarmiento Angulo" Cancer Treatment and Research Center (CTIC)
Attend LALCA 2024 to discover advancements in lung cancer therapies, encompassing ongoing clinical trials and comprehensive insights into preclinical and early clinical breakthroughs. Gain invaluable perspectives on addressing critical disparities in the region, arming yourself with actionable insights to drive change and enhance patient outcomes. https://lnkd.in/eBcCzpyR
#LALCA24 - LALCA24 - Grand Hyatt Bogota
lalca2024-iaslc.org
To view or add a comment, sign in
-
Chronic inflammation and cancer👉 how can preclinical models revolutionize our understanding? It is now well established that chronic unresolved inflammation may lead to the initiation and development of #cancers (approximately 20-25% of cancer cases). In this publication on Labiotech.eu, Olivier Duchamp highlights that a better understanding and modelizing of the chronic inflammation process could help develop new anti-inflammatory strategies for cancer prevention and treatment. Read the article 👇 https://buff.ly/3zp0olY
To view or add a comment, sign in
-
🌟 Celebrating Cancer Research Awareness Day 🌟 Today, we team up for cancer research. At Indivumed Therapeutics, we are committed to advancing precision oncology and deliver on the promise in finding novel targets for innovative drug development. On this important day, we honor the researchers, clinicians, and especially patients affected, who drive us. Together, we are revolutionizing cancer treatment and improving lives. 💪💙 #CancerResearchAwarenessDay #PrecisionOncology #InnovativeTherapeutics #HighQualityData #DataAnalytics
To view or add a comment, sign in
-
Biomarker testing has transformed the cancer treatment landscape, significantly improving patient outcomes by identifying ‘actionable’ targets. Just as each lung cancer patient is unique, so too should be their treatment approach. Learn more about how we are advancing biomarker awareness and driving treatment innovations: https://bit.ly/3YpMBWM #BiomarkerTesting #WorldLungCancerDay
To view or add a comment, sign in
4,211 followers